Cargando…

Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via β1-Integrin Activation in Fibroblasts

Inflammatory bowel diseases increase the risk of colorectal cancer and colitis-associated colorectal cancer (CAC). Tenascin-C, a matricellular protein, is highly expressed in inflammatory bowel diseases, especially colorectal cancer. However, the role of tenascin-C in the development of CAC is not y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Motomichi, Ito-Fujita, Yuka, Iyoda, Takuya, Sasada, Manabu, Okada, Yuko, Ishibashi, Kazuma, Osawa, Takuro, Kodama, Hiroaki, Fukai, Fumio, Suzuki, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601010/ https://www.ncbi.nlm.nih.gov/pubmed/31195598 http://dx.doi.org/10.3390/ijms20112752

Ejemplares similares

The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration
por: Suzuki, Hideo, et al.
Publicado: (2017)

Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells
por: Fujita, Motomichi, et al.
Publicado: (2019)

Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma
por: Iyoda, Takuya, et al.
Publicado: (2020)

Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide
por: Fujita, Motomichi, et al.
Publicado: (2020)

Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression
por: Fujita, Motomichi, et al.
Publicado: (2021)

Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation
por: Iyoda, Takuya, et al.
Publicado: (2012)

Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins
por: Sasada, Manabu, et al.
Publicado: (2019)

Tenascin-C and integrins in cancer
por: Yoshida, Toshimichi, et al.
Publicado: (2015)

Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim
por: Iyoda, Takuya, et al.
Publicado: (2016)

Suppression of injury-induced epithelial-mesenchymal transition in a mouse lens epithelium lacking tenascin-C
por: Tanaka, Sai-ichi, et al.
Publicado: (2010)

Tenascin-C is a driver of inflammation in the DSS model of colitis
por: Ozanne, James, et al.
Publicado: (2022)

Tenascin-C as a potential marker for immunohistopathology of doxorubicin-induced cardiomyopathy
por: Nishikawa, Tatsuya, et al.
Publicado: (2023)

Inhibition of Fibrous Adhesion Formation in the Temporomandibular Joint of Tenascin-C Knockout Mice
por: Shinohara, Y., et al.
Publicado: (2014)

Loss of tenascin X gene function impairs injury‐induced stromal angiogenesis in mouse corneas
por: Sumioka, Takayoshi, et al.
Publicado: (2017)

Generation of Transgenic Mice that Conditionally Overexpress Tenascin-C
por: Yonebayashi, Saori, et al.
Publicado: (2021)

The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C
Publicado: (1994)

134. KRP-A218, an Orally Active and Selective PI4KB Inhibitor with Broad-Spectrum Anti-Rhinovirus Activity, Has Potent Therapeutic Antiviral Activity In vivo
por: Matsui, Toshiyuki, et al.
Publicado: (2021)

The Role of Tenascin-C in Tissue Injury and Repair After Stroke
por: Okada, Takeshi, et al.
Publicado: (2021)

Expression and degeneration of tenascin-C in human lung cancers.
por: Kusagawa, H., et al.
Publicado: (1998)

Tenascin turns on the EGFR
por: Jegalian, Karin
Publicado: (2001)

The evolution of tenascins and fibronectin
por: Adams, Josephine C, et al.
Publicado: (2015)

The influence of bisphosphonates on human osteoblast migration and integrin aVb3/tenascin C gene expression in vitro
por: Koch, Felix P, et al.
Publicado: (2011)

Invasion of Melanoma in Double Knockout Mice Lacking Tenascin‐X and Tenascin‐C
por: Matsumoto, Ken‐ichi, et al.
Publicado: (2002)

Tenascin-C Enhances Pancreatic Cancer Cell Growth and Motility and Affects Cell Adhesion through Activation of the Integrin Pathway
por: Paron, Igor, et al.
Publicado: (2011)

Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells
por: Naik, Adviti, et al.
Publicado: (2018)

Induction of tenascin in healing wounds
Publicado: (1988)

Tenascin Supports Lymphocyte Rolling
por: Clark, Rachael A., et al.
Publicado: (1997)

Advances in tenascin-C biology
por: Midwood, Kim S., et al.
Publicado: (2011)

Transcriptional regulation of tenascin genes
por: Chiovaro, Francesca, et al.
Publicado: (2015)

Immunosuppression via Tenascin-C
por: Bellone, Matteo, et al.
Publicado: (2015)

Tenascin-X and the pick of destiny
por: Short, Ben
Publicado: (2014)

Tenascin C in Lung Diseases
por: Donovan, Chantal, et al.
Publicado: (2023)

Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis
Publicado: (1991)

Early Days of Tenascin-R Research: Two Approaches Discovered and Shed Light on Tenascin-R
por: Rathjen, Fritz G., et al.
Publicado: (2021)

Tenascin-C Expression in Equine Tendon-derived Cells During Proliferation and Migration
por: NEMOTO, Manabu, et al.
Publicado: (2013)

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
por: Brellier, Florence, et al.
Publicado: (2012)

Virtual Screening of Protein Data Bank via Docking Simulation Identified the Role of Integrins in Growth Factor Signaling, the Allosteric Activation of Integrins, and P-Selectin as a New Integrin Ligand
por: Takada, Yoshikazu, et al.
Publicado: (2023)

Development of a homogeneous time-resolved fluorescence assay for detection of viral double-stranded RNA
por: Fujita, Motomichi, et al.
Publicado: (2019)

Tenascin-C Suppresses Rho Activation
por: Wenk, Melissa B., et al.
Publicado: (2000)

The Adhesion Modulating Properties of Tenascin-W
por: Brellier, Florence, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_179fcg89e7ckujah8psk51sk2t